MAPT and frontotemporal dementia: Considering that most tau tracers show non-specific/off-target binding with considerable overlap with TDP-43 pathology, the ongoing development of PET tracers specific for TDP-43 aggregates could have significant implications not only for FTD but also for ALS research84.